Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Mouse Ladder-Climb Protocol Induces Acute Anabolic Signaling and Muscle-Specific Adaptations to Resistance Training.

Acta physiologica (Oxford, England)·2026
Same author

One Step Closer to Real-Time Detection of Missed Opportunities for Diagnosis in the ED Using LLMs.

JAMA network open·2026
Same author

Recovery Kinetics and Persistent Hepatic Alterations in a Xenobiotic-induced Murine Model of Chronic Cholestatic Liver Disease.

Current molecular medicine·2026
Same author

Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ.

JCI insight·2026
Same author

Reelin regulates the migration and differentiation of extravillous trophoblastic cells.

Biological research·2026
Same author

Corrigendum for "Oxygen and TGF-β1 jointly regulate fibronectin and trophoblast behavior highlighting a potential role for matrix signaling in severe preeclampsia" [Matrix Biology 144 (2026) 13-25].

Matrix biology : journal of the International Society for Matrix Biology·2026

Related Experiment Video

Updated: May 9, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.

Maria Gabriela Morales1, Jaime Gutierrez, Claudio Cabello-Verrugio

  • 1Laboratorio de Diferenciación Celular y Patología, Centro de Regulación Celular y Patología (CRCP), Centro de Regeneración y Envejecimiento (CARE), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.

Human Molecular Genetics
|August 2, 2013
PubMed
Summary

Reducing connective tissue growth factor (CTGF) significantly lessens the severity of Duchenne muscular dystrophy (DMD) in mdx mice. This approach improves muscle function and enhances cell therapy outcomes for DMD.

More Related Videos

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Related Experiment Videos

Last Updated: May 9, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Duchenne muscular dystrophy (DMD) results from a lack of dystrophin, leading to muscle fiber damage, fibrosis, and weakness.
  • Connective tissue growth factor (CTGF/CCN-2) is implicated in fibrotic diseases and may contribute to the dystrophic phenotype in DMD.

Purpose of the Study:

  • To investigate the therapeutic potential of reducing CTGF availability in the mdx mouse model of DMD.
  • To assess the impact of CTGF suppression on disease progression, muscle function, and cell therapy efficacy.

Main Methods:

  • Utilized two independent approaches: genetic deletion of one CTGF allele (mdx-Ctgf+/-) and treatment with an anti-CTGF monoclonal antibody (FG-3019).
  • Evaluated muscle performance via exercise endurance tests and isolated muscle strength assessments.
  • Quantified skeletal muscle impairment, apoptotic damage, and fibrosis.
  • Assessed downstream signaling pathways including TGF-β, pERK1/2, and p38.
  • Examined the effect of CTGF suppression on the grafting of dystrophin-positive satellite cells.

Main Results:

  • Mdx mice with reduced CTGF showed improved exercise endurance and muscle strength.
  • Skeletal muscle impairment, apoptosis, and fibrosis were significantly reduced in CTGF-suppressed mdx mice.
  • CTGF suppression did not affect TGF-β, pERK1/2, or p38 signaling pathways.
  • Grafting of dystrophin-positive satellite cells was improved in mdx mice with reduced CTGF.

Conclusions:

  • Reducing CTGF availability ameliorates the dystrophic phenotype in mdx mice.
  • Targeting CTGF represents a promising strategy to slow DMD progression.
  • CTGF suppression may enhance the effectiveness of cell-based therapies for DMD.